Lois A. Chandler

Biography

  Dr. Chandler has served as Vice President, Biologics Development of Cardium since July 2010 and served as Senior Director, Product Development of Cardium’s wholly-owned subsidiary, Tissue Repair Company, from August 2006 to July 2010. Dr. Chandler has 17 years of professional experience in biopharmaceutical design and clinical development, Chemistry, Manufacturing and Controls, Quality Control and custom DNA vector design. Prior to joining Tissue Repair Company in January 2006, Dr. Chandler served as Associate Director, Vector Development for Selective Genetics Inc., a company that developed targeted viral and non-viral DNA therapeutics for dermal, cardiovascular, and orthopedic tissue repair. At Selective Genetics, Dr. Chandler oversaw the developmental Chemistry, Manufacturing and Control efforts related to Excellarate and Excellagen as well as other targeted gene therapy preclinical programs. She also served as Supervisor of the Molecular Biology, Analytical Development and Assay Development departments. Prior to Selective Genetics, Dr. Chandler was employed by Prizm Pharmaceuticals as a Senior Scientist, Molecular Biology designing novel recombinant mitotoxins for proliferative disorders. Dr. Chandler received a B.S. in Chemistry from Stanford University, Palo Alto, CA, and a Ph.D. in Biochemistry from the University of Southern California with emphasis on the epigenetics of cancer.

Research Interest